So far in 2024, the healthcare sector has returned 8.5%. This is roughly on par with the long-term average return of the S&P 500. While that's not too shabby, growth investors may be looking for something a little more enticing.

Within the broader healthcare sector, the drug manufacturers market has generated a return of 14.3% so far in 2024 and 17.3% over the last year. One of the biggest players among drug manufacturers is Eli Lilly (NYSE: LLY). With shares up 82% over the last 12 months, Lilly looks absolutely unstoppable.

Despite this meteoric rise, I think Lilly's gains are just getting started. Let's break down what's fueling Lilly's growth right now, and explore why the company's future prospects look bright.

Continue reading

Source Fool.com